WHO ICTRP trial
A PHASE Ia/Ib STUDY OF STA551 AS A SINGLE AGENT AND IN COMBINATION WITH…
JPRN-jRCT2080225058 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT2080225058 |
|---|---|
| Public title | A PHASE Ia/Ib STUDY OF STA551 AS A SINGLE AGENT AND IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH SOLID TUMORS |
| Scientific title | A PHASE Ia/Ib OPEN-LABEL, DOSE-ESCALATION STUDY OF THE SAFETY AND PHARMACOKINETICS OF STA551 AS A SINGLE AGENT AND IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS |
| Primary sponsor | Chugai Pharmaceutical Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Countries | Japan;Europe;Asia exept Japan |
| Conditions | LOCALLY ADVANCED OR METASTATIC SOLID TUMORS |
| Interventions | investigational material(s) Generic name etc : STA551 INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Intravenous infusion Generic name etc… |
| Registration date | Dec 2, 2020 |
| Target size | 233 |
| Secondary IDs | 2019-003329-11;JapicCTI-205153 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: